PMID: 15328698Aug 27, 2004Paper

Coagulation for treatment of paint industry wastewater

Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering
Olga DovletoglouHelen Grigoropoulou

Abstract

In the present study, the coagulation of paint industry wastewater was examined. Ferrous and aluminum sulphate and polyaluminum chloride (PACl) were used as coagulation agents and the influence of the coagulant dose and effective pH on the quality of treated wastewater was investigated. Optimum pH for FeSO4 addition was near 9.7, the required coagulant dose was about 2 g/L and average process efficiency varied between 30 and 80% in COD and between 70 and 99% in turbidity terms, for a wide spectrum of wastewater batches. In the case of Al2(SO4)3, no pH adjustment was needed and process efficiency varied between 70 and 95% in COD and between 90 and 99% in turbidity terms, for an effective dose of 2.5 g/L. Further improvement of process efficiency was possible by raising the pH of the supernatant liquid after alum-sludge sedimentation to 10. In the case of PACl optimum pH was around 7 and process efficiency was about 98% based on both quality parameters, for an effective dose of 4 g/L. Cationic polyelectrolytes were proved to have a higher potential vs. coagulation than anionic ones when acting as primary coagulants. Combination of Al2(SO4)3 or PACl with polyelectrolytes resulted in high process efficiencies, while maintaining liq...Continue Reading

Citations

Mar 22, 2007·Journal of Hazardous Materials·Bahadir K KörbahtiAbdurrahman Tanyolaç
Aug 6, 2016·Journal of Environmental Management·E GiannakopoulosI K Kalavrouziotis
Jul 20, 2006·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Gulen EremektarSerdar Dogruel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.